On Ozempic or Mounjaro Before Surgery? Here's What Your Anesthesiologist Needs to Know

On Ozempic or Mounjaro Before Surgery? Here's the Decision Your Anesthesiologist Is Already Making For You

Most people on GLP-1 medications think the biggest risk before surgery is their blood sugar or blood pressure. Turns out, the risk your surgical team is most worried about right now is your stomach — specifically, whether it's actually empty when it's supposed to be.

New research using bedside ultrasound is changing how anesthesiologists prep patients on semaglutide, tirzepatide, and other GLP-1 drugs before going under. And if your surgeon or anesthesiologist hasn't asked you about your GLP-1 yet, you need to bring it up yourself.

Important: I'm not a doctor. Everything I share here is based on published research and editorial review. Talk to your physician and anesthesiologist before any procedure — especially if you're on a GLP-1 medication.

---

The Bottom Line

• GLP-1 drugs like Ozempic and Mounjaro slow how fast food leaves your stomach — even when you've followed standard fasting instructions before surgery.
• A stomach that isn't fully empty during anesthesia creates a real risk: stomach contents can enter the lungs (called aspiration), which can be life-threatening.
• New research shows gastric ultrasound — a quick bedside scan — can check your stomach's contents before anesthesia, giving doctors real-time information to act on.
• The decision isn't whether to have surgery. It's whether your team knows you're on a GLP-1, and whether they're checking your stomach before proceeding.
• Actionable takeaway: Tell every member of your surgical team you're taking a GLP-1 drug, when you last took it, and ask if your facility uses pre-anesthesia gastric ultrasound.

---

Why GLP-1 Drugs Complicate Anesthesia — Even When You've Fasted

Here's the thing about GLP-1 receptor agonists: slowing digestion is part of why they work so well for weight loss and blood sugar control. They pump the brakes on gastric emptying, meaning food and liquid sit in your stomach longer than normal.

That's a feature when you're trying to feel full after a smaller meal.

It becomes a problem when you're lying on an operating table.

Standard anesthesia protocols assume that if you haven't eaten for 6-8 hours (and haven't had clear liquids for 2 hours), your stomach is empty enough to proceed safely. But GLP-1 medications can slow gastric emptying so significantly that even people who followed the rules correctly may still have a stomach full of undigested food at surgery time.

The danger? When you're under general anesthesia, your protective reflexes — the ones that normally prevent you from inhaling stomach contents — are turned off. If your stomach isn't empty and you vomit or regurgitate, that material can enter your lungs. This is called pulmonary aspiration, and it can cause serious pneumonia or, in severe cases, respiratory failure.

According to a 2024 study published in JAMA, patients on GLP-1 receptor agonists showed significantly higher rates of residual gastric content before elective procedures compared to patients not on these medications — even after following standard fasting protocols. That's a meaningful finding that is reshaping pre-surgical prep worldwide.

---

The Two-Option Decision: Standard Fasting Protocol vs. Gastric Ultrasound Assessment

This is the real decision being made right now in hospitals and surgical centers everywhere — and as a patient on a GLP-1, you should understand what's at stake.

Option 1: Follow Standard Fasting Rules and Hope for the Best

The traditional approach. You stop eating solid food the night before, stop clear liquids two hours before your procedure, and your team assumes you're good to go.

For patients not on GLP-1 drugs, this works reliably well. Decades of data support it.

For patients on GLP-1 drugs, the evidence increasingly suggests this assumption is unreliable. Your stomach may be slower than your fasting window can account for.

Who this option works for: People who have already stopped their GLP-1 medication far enough in advance (more on timing below), or patients having procedures where aspiration risk is lower and general anesthesia is not involved.

The downside: If nobody on your team knows you're on a GLP-1, or if they know but don't adjust the plan, you're going into surgery with an unknown amount of residual gastric content and no way to check.

---

Option 2: Pre-Anesthesia Gastric Ultrasound Assessment

This is the newer, smarter approach. A trained anesthesiologist or sonographer uses a portable ultrasound probe to image your stomach — right there, before your procedure begins — to see if there's food or liquid in it.

It takes about five minutes. It doesn't require fasting blood draws, X-rays, or any invasive steps.

The stomach is actually well-suited for ultrasound imaging. A published assessment study from PubMed found that gastric ultrasound could reliably classify patients into "empty stomach," "clear liquid only," or "solid content present" categories before anesthesia. For patients on GLP-1 agonists specifically, this real-time information allows the anesthesiologist to adjust the plan — delay the procedure, choose a different airway technique, or take additional precautions.

Who this option works best for: Anyone currently on a GLP-1 medication scheduled for a procedure requiring general anesthesia, sedation, or deep sedation. Especially relevant for same-day surgical centers where fasting histories are harder to verify.

The downside: Not every facility has this protocol in place. You may need to specifically ask, and some centers may not yet offer it as standard practice.

---

What the Research Actually Shows

The concern about GLP-1 drugs and gastric content is not theoretical. Multiple studies have now documented the real-world scope of this issue.

A review of cases involving GLP-1 users going under anesthesia found that residual solid gastric content was present in some patients even after 12+ hours of fasting. In non-GLP-1 patients, that would be highly unusual.

The JAMA-published assessment study specifically evaluated gastric ultrasound as a tool for this exact population and found it to be a practical, reliable method for identifying high-risk patients before anesthesia is administered. The key advantage: it gives the anesthesiologist real data instead of assumptions.

The American Society of Anesthesiologists (ASA) updated its guidance in 2023 to specifically address GLP-1 users before elective procedures, recommending that patients stop their weekly GLP-1 injection one week before surgery when possible. For daily GLP-1 formulations, the recommendation was to skip the dose the day before.

However, the guidelines also acknowledge that this isn't always possible — some patients take GLP-1s for diabetes management and can't safely stop them, and emergencies don't wait for a week-long washout.

That's exactly where gastric ultrasound becomes the practical bridge between what should have happened and what you actually do now.

---

The Timing Question: When Should You Stop Your GLP-1 Before Surgery?

This is where the decision gets personal, and where you genuinely need to talk to your prescribing doctor before your surgical team makes assumptions.

Here's a general breakdown based on current ASA guidance and published research — note that this is educational, not medical advice, and individual situations vary significantly.

Weekly injectable GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound): The current recommendation is to skip the weekly dose immediately before surgery — meaning if surgery is on a Thursday, you would not take your Sunday dose. The half-life of these drugs is long, so one missed dose doesn't eliminate the effect, but it meaningfully reduces it.

Daily injectable GLP-1s (Victoza/liraglutide): Skip the dose the day of surgery. Some providers suggest skipping the day before as well, particularly for procedures with higher aspiration risk.

Oral GLP-1s (Rybelsus/oral semaglutide): Shorter acting than injectables, so the day-of-surgery skip is the primary guidance. Still, always confirm with your anesthesiologist.

Important nuance: If you're taking a GLP-1 for type 2 diabetes control and stopping it might destabilize your blood sugar, your surgeon and endocrinologist need to be in communication before the procedure to manage this tradeoff. Do not just stop your medication without guidance.

---

What Gastric Ultrasound Actually Looks Like in Practice

If you've never had a gastric ultrasound, it's less intimidating than it sounds.

You lie down. The anesthesiologist or sonographer places a small ultrasound probe on your upper abdomen, just below your ribcage on the right side. They look at the antrum — the lower portion of the stomach — and measure its cross-sectional area.

A small, flat antrum means your stomach is empty. A larger antrum with visible content means there's something in there.

From that measurement, the provider can estimate gastric volume with reasonable accuracy. Published research shows antral cross-sectional area correlates well with actual gastric content, even when compared to gold-standard gastric aspiration methods.

The whole scan takes five minutes or less. And the information it provides can change the entire management plan before a single drop of anesthetic is given.

For patients on GLP-1 drugs who did everything right but still have residual gastric content — which the research shows happens — this scan is the safety net that standard fasting protocols can't provide.

---

Who Should Specifically Ask About Gastric Ultrasound

Not every GLP-1 user needs to demand a pre-op stomach scan. But certain patients should proactively ask the question.

Ask specifically about gastric ultrasound if:

• You're currently taking a weekly GLP-1 injection and your surgery is within one week of your last dose
• You've been experiencing GI symptoms — nausea, bloating, slow digestion — which are common GLP-1 side effects that suggest significant gastric slowing
• You have diabetes and couldn't stop your GLP-1 medication before surgery due to blood sugar management concerns
• You're having an emergency or urgent procedure where the standard one-week washout wasn't possible
• You're having a procedure under general anesthesia (vs. local or regional anesthesia, where the risk is lower)
• Your procedure is at an ambulatory surgical center where pre-op history-taking may be briefer

You may not need it if:

• You've been off your weekly GLP-1 for more than a week before surgery
• Your procedure is under local or regional anesthesia only
• You're having an endoscopy or procedure specifically to evaluate your GI tract, where the team is already prepared for full stomach scenarios

---

The Practical Conversation to Have Before Any Procedure

Here's exactly what to say — or bring up in writing — when you talk to your surgical team.

"I'm currently taking [drug name] for [weight management/type 2 diabetes]. My last dose was [date]. I've read that GLP-1 medications can delay gastric emptying and may affect anesthesia safety. Does your facility use pre-anesthesia gastric ultrasound for patients on GLP-1 drugs? And do you want me to adjust my dosing schedule before the procedure?"

That's it. That one conversation, done before surgery day, gives your anesthesiologist the information they need to make the right call.

The worst outcome here isn't a delayed procedure. It's going into surgery with a full stomach that nobody knew about, in a body whose protective reflexes are chemically turned off.

---

FAQ

Can I still have surgery if I'm on Ozempic or Mounjaro? Yes, in most cases. The concern isn't the medication itself — it's the effect on gastric emptying and the potential for aspiration under anesthesia. With proper preparation and communication, most patients on GLP-1 drugs can have procedures safely. Your anesthesiologist needs to know you're taking these medications so they can adjust their approach.

What happens if I have a full stomach under general anesthesia? This is called aspiration risk. If stomach contents enter the lungs during anesthesia, it can cause aspiration pneumonia or, in severe cases, acute respiratory failure. It's a serious complication, which is why anesthesiologists take pre-op fasting so seriously — and why this issue with GLP-1 drugs has gotten significant attention.

Will stopping Ozempic for one week before surgery undo my progress? Missing one weekly dose of semaglutide or tirzepatide is unlikely to meaningfully impact your long-term progress. The drugs have long half-lives, and your metabolic adaptations don't reverse in a week. The small temporary disruption is worth the safety benefit. That said, if you're on a GLP-1 for diabetes management, talk to your doctor before adjusting your dose.

Is gastric ultrasound available at every hospital or surgical center? Not yet. It's becoming more standard at larger academic medical centers and anesthesiology practices that have invested in point-of-care ultrasound training. Smaller ambulatory surgical centers may not have it. If it's not available at your facility, the conversation about timing your last GLP-1 dose becomes even more important.

How long does it take for GLP-1 drugs to stop affecting gastric emptying? This varies by drug and individual. For weekly injectables like semaglutide and tirzepatide, the gastric effects can persist for several days after the last dose due to their long half-lives. This is why the current guidance suggests one week off before elective surgery when possible — not because the drug is out of your system entirely, but because the gastric slowing effect is meaningfully reduced.

---

The Bottom Line: You Need to Be the One Who Brings This Up

Here's the honest reality: the research on GLP-1 drugs and anesthesia safety is newer than most surgical protocols. Many surgical centers haven't fully updated their intake forms to ask specifically about GLP-1 use. Your anesthesiologist may assume a standard fasting protocol is sufficient.

You know something they may not have asked you yet.

Gastric ultrasound is a practical, five-minute solution that gives your anesthesiologist real information when assumptions aren't enough. If your facility offers it, ask for it. If they don't, make sure your team knows about your GLP-1 use and when you last took it — and have the conversation about dosing timing well before your procedure date.

The medication that's helping your metabolic health deserves to be managed thoughtfully, not just around your daily routine, but around every medical encounter it touches. Including — especially — the ones where you'll be unconscious.

---

Medical Disclaimer: The information on this website is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol, medication, or supplement regimen. Individual results vary. The author shares personal experience and published research — not medical recommendations.

---

Sources

1. Assessment of Gastric Content Using Gastric Ultrasound in Patients on GLP-1 Receptor Agonists Before Anesthesia — PubMed, 2024
2. Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes — Diabetes Therapy, 2026
3. A Narrative Review of the Metabolic Benefits of GLP-1 and GIP Receptor Agonists in Obesity — PubMed, 2026
4. [Relationship of Early Rapid Weight Loss to Efficacy and Safety of Tirzepatide and Semaglutide: SURMOUNT-5 Post Hoc Analysis](https://pubmed.ncbi.nl